Comparative In Vitro Evaluation of BL-P1654 and Carbenicillin Against Pseudomonas
AUTOR(ES)
Overturf, G. D.
RESUMO
Prior investigators have reported a broad gram-negative spectrum and a marked anti-Pseudomonas activity in vitro with BL-P1654, 6-[R-alpha-(guanylureido)phenylacetamido]-penicillanic acid. An in vitro comparison of BL-P1654 to carbenicillin was performed against 84 strains of Pseudomonas and 39 strains of Enterobacteriaceae. Mean minimal inhibitory concentrations in Mueller-Hinton broth of BL-P1654 and carbenicillin were 12.5 and 100 μg/ml, respectively. Bactericidal studies with representative strains of Pseudomonas showed a consistent lack of bactericidal activity with BL-P1654. Mean bactericidal concentrations of BL-P1654 and carbenicillin were ≥200 and 100 μg/ml, respectively. The lack of bactericidal activity of BL-P1654 was further substantiated with the “killing curve” technique. Based on these data, BL-P1654 can not be considered a substitute for carbenicillin as the penicillin analogue of choice for Pseudomonas infections.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444707Documentos Relacionados
- Comparison of the In Vitro Activity of BL-P1654 with Gentamicin and Carbenicillin Against Pseudomonas aeruginosa
- Comparative Activity In Vitro of Ticarcillin, BL-P1654, and Carbenicillin
- BL-P1654, Ticarcillin, and Carbenicillin: In Vitro Comparison Alone and in Combination with Gentamicin Against Pseudomonas aeruginosa
- Human Pharmacokinetics of BL-P1654 Compared with Ampicillin
- Human Pharmacokinetics of BL-P1654 Compared with Ampicillin